MitoQ (Asthma) - Clinical Trial

What is the Purpose of this Study?


We are doing this study to see if an anti-oxidant pill called mitoquinol (mitoQ) might be helpful to control asthma.

What is the Condition Being Studied?


Who Can Participate in the Study?

Key Eligibility

Adults age 18 and older who:
- Are diagnosed with asthma
- Do not smoke
- Are using a regular asthma controller (preventative) medication but still have asthma symptoms
- Have a BMI of 30 kg/m2 or higher
- Have not taken mitoquinol or a similar supplement like idebenone or co-enzyme Q10 in the last 8 weeks

For more information about who can join this study, please contact the study team at (919) 479-0861 or email

Age Group

What is Involved?


If you choose to join this study, you will:
- Take a daily dose of the study supplement (mitoQ) or a placebo (inactive substance), in pill form, for 12 weeks
- Visit our clinic 6 times over 14 weeks
- Have your lung function tested
- Give blood and urine samples
- Answer questionnaires
- Keep a daily diary of your asthma symptoms

You can take a survey online to see if you might be eligible and to have a study team member contact you:

Study Details

Full Title
MitoQ for the treatment of Metabolic Dysfunction in Asthma
Principal Investigator
Protocol Number
IRB: PRO00102278
NCT: NCT04026711
Phase Pilot
Enrollment Status
Open for Enrollment